161 related articles for article (PubMed ID: 36878665)
1. Association between physical activity and the time course of cancer recurrence in stage III colon cancer.
Brown JC; Ma C; Shi Q; Niedzwiecki D; Zemla T; Couture F; Kuebler P; Kumar P; Hopkins JO; Tan B; Krishnamurthi S; O'Reilly EM; Shields AF; Meyerhardt JA
Br J Sports Med; 2023 Aug; 57(15):965-971. PubMed ID: 36878665
[TBL] [Abstract][Full Text] [Related]
2. Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
Van Blarigan EL; Fuchs CS; Niedzwiecki D; Zhang S; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Giovannucci EL; Ng K; Meyerhardt JA
JAMA Oncol; 2018 Jun; 4(6):783-790. PubMed ID: 29710284
[TBL] [Abstract][Full Text] [Related]
3. Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
Brown JC; Ma C; Shi Q; Zemla T; Couture F; Kuebler P; Kumar P; Tan B; Krishnamurthi S; Chang V; Goldberg RM; Venook AP; Blanke CD; O'Reilly EM; Shields AF; Meyerhardt JA
Cancer; 2023 Dec; 129(23):3724-3734. PubMed ID: 37651160
[TBL] [Abstract][Full Text] [Related]
4. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA; Heseltine D; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Thomas J; Nelson H; Whittom R; Hantel A; Schilsky RL; Fuchs CS
J Clin Oncol; 2006 Aug; 24(22):3535-41. PubMed ID: 16822843
[TBL] [Abstract][Full Text] [Related]
5. Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).
Brown JC; Ma C; Shi Q; Fuchs CS; Meyer J; Niedzwiecki D; Zemla T; Couture F; Kuebler P; Kumar P; Lewis D; Tan B; Krishnamurthi S; O'Reilly EM; Shields AF; Meyerhardt JA
J Clin Oncol; 2023 Jan; 41(2):243-254. PubMed ID: 35944235
[TBL] [Abstract][Full Text] [Related]
6. Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
Meyerhardt JA; Shi Q; Fuchs CS; Meyer J; Niedzwiecki D; Zemla T; Kumthekar P; Guthrie KA; Couture F; Kuebler P; Bendell JC; Kumar P; Lewis D; Tan B; Bertagnolli M; Grothey A; Hochster HS; Goldberg RM; Venook A; Blanke C; O'Reilly EM; Shields AF
JAMA; 2021 Apr; 325(13):1277-1286. PubMed ID: 33821899
[TBL] [Abstract][Full Text] [Related]
7. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
[TBL] [Abstract][Full Text] [Related]
8. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
Meyerhardt JA; Niedzwiecki D; Hollis D; Saltz LB; Hu FB; Mayer RJ; Nelson H; Whittom R; Hantel A; Thomas J; Fuchs CS
JAMA; 2007 Aug; 298(7):754-64. PubMed ID: 17699009
[TBL] [Abstract][Full Text] [Related]
9. Effect of the duration of the capecitabine regimen following colon cancer surgery in an elderly population: a retrospective cohort study.
Chen W; Dong H; Wang G; Chen J; Wang W
World J Surg Oncol; 2021 Aug; 19(1):238. PubMed ID: 34380513
[TBL] [Abstract][Full Text] [Related]
10. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
Tie J; Cohen JD; Wang Y; Christie M; Simons K; Lee M; Wong R; Kosmider S; Ananda S; McKendrick J; Lee B; Cho JH; Faragher I; Jones IT; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Li L; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
JAMA Oncol; 2019 Dec; 5(12):1710-1717. PubMed ID: 31621801
[TBL] [Abstract][Full Text] [Related]
11. Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
Fadelu T; Zhang S; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson AB; Atienza DM; Messino M; Kindler HL; Venook A; Ogino S; Ng K; Wu K; Willett W; Giovannucci E; Meyerhardt J; Bao Y; Fuchs CS
J Clin Oncol; 2018 Apr; 36(11):1112-1120. PubMed ID: 29489429
[TBL] [Abstract][Full Text] [Related]
12. Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.
Shah MA; Renfro LA; Allegra CJ; André T; de Gramont A; Schmoll HJ; Haller DG; Alberts SR; Yothers G; Sargent DJ
J Clin Oncol; 2016 Mar; 34(8):843-53. PubMed ID: 26811529
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database.
Salem ME; Yin J; Goldberg RM; Pederson LD; Wolmark N; Alberts SR; Taieb J; Marshall JL; Lonardi S; Yoshino T; Kerr RS; Yothers G; Grothey A; Andre T; De Gramont A; Shi Q
Ann Oncol; 2020 Apr; 31(4):480-486. PubMed ID: 32085892
[TBL] [Abstract][Full Text] [Related]
14. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA; Sato K; Niedzwiecki D; Ye C; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Wigler DS; Venook A; Fuchs CS
J Natl Cancer Inst; 2012 Nov; 104(22):1702-11. PubMed ID: 23136358
[TBL] [Abstract][Full Text] [Related]
15. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.
Vermorken JB; Claessen AM; van Tinteren H; Gall HE; Ezinga R; Meijer S; Scheper RJ; Meijer CJ; Bloemena E; Ransom JH; Hanna MG; Pinedo HM
Lancet; 1999 Jan; 353(9150):345-50. PubMed ID: 9950438
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
Singh PP; Shi Q; Foster NR; Grothey A; Nair SG; Chan E; Shields AF; Goldberg RM; Gill S; Kahlenberg MS; Sinicrope FA; Sargent DJ; Alberts SR
Oncologist; 2016 Dec; 21(12):1509-1521. PubMed ID: 27881709
[TBL] [Abstract][Full Text] [Related]
17. Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
Chan JA; Meyerhardt JA; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Thomas J; Schaefer P; Whittom R; Hantel A; Goldberg RM; Warren RS; Bertagnolli M; Fuchs CS
JAMA; 2008 Jun; 299(21):2515-23. PubMed ID: 18523220
[TBL] [Abstract][Full Text] [Related]
18. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature.
Böckelman C; Engelmann BE; Kaprio T; Hansen TF; Glimelius B
Acta Oncol; 2015 Jan; 54(1):5-16. PubMed ID: 25430983
[TBL] [Abstract][Full Text] [Related]
19. LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.
Lou YT; Chen CW; Fan YC; Chang WC; Lu CY; Wu IC; Hsu WH; Huang CW; Wang JY
PLoS One; 2014; 10(4):e0123973. PubMed ID: 25919688
[TBL] [Abstract][Full Text] [Related]
20. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group.
Goldberg RM; Fleming TR; Tangen CM; Moertel CG; Macdonald JS; Haller DG; Laurie JA
Ann Intern Med; 1998 Jul; 129(1):27-35. PubMed ID: 9652996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
